This compound is a pharmaceutical intermediate used in the synthesis of nucleoside analogs. It features a multi-ring structure with ester and halogen functional groups, making it suitable for further chemical modification in research and manufacturing settings.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1019659-88-1
Uridine, 2'-deoxy-2'-fluoro-, 3',5'-diacetate
Pharmaceutical intermediate for nucleoside analogs
(2R,3R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4,4-difluorotetrahydrofuran-3-yl benzoate
Pharmaceutical intermediate for nucleoside analogs
((2R,3R,5R)-3-(Benzoyloxy)-4,4-difluoro-5-((methylsulfonyl)oxy)tetrahydrofuran-2-yl)methyl benzoate
Pharmaceutical intermediate for nucleoside analogs
9-(2-Deoxy-2-fluoroarabinofuranosyl)guanine
Pharmaceutical intermediate for nucleoside analogs
Ethyl 3-(3-chloro-2,4,5-trifluorophenyl)-3-oxopropanoate
Pharmaceutical intermediate
2-chloro-4-(chloromethyl)pyridine
pharmaceutical intermediate
1,3-Diphenylurea
Pharmaceutical intermediate for organic synthesis
N-(3-Aminophenyl)acetamide
synthetic intermediate in organic synthesis
[(2R,3S,5S)-5-acetyloxy-3-(4-chlorobenzoyl)oxyoxolan-2-yl]methyl 4-chlorobenzoate
XHRJNOXRTTZFEQ-IPMKNSEASA-N
CC(=O)O[C@H]1C[C@@H]([C@H](O1)COC(=O)C2=CC=C(C=C2)Cl)OC(=O)C3=CC=C(C=C3)Cl